Dr. Clausell earned his doctoral degree in Clinical-Community Psychology from the University of Illinois at Urbana-Champaign in 2011. Dr. Clausell’s graduate research focused on the legacy of childhood attachment relationships on relationship satisfaction of Gay and Lesbian Romantic Couples. Results of this research were published in the journal Developmental Psychology (2008). He completed his Predoctoral Clinical Internship at Veterans Affairs Palo Alto Health Care System and served as a Postdoctoral Research Fellow in Clinical Psychology in the Department of Psychiatry and Behavioral Sciences, Stanford Medicine. Dr. Clausell currently serves as the Director of the Couples & Family Program at Veterans Affairs Puget Sound Health Care System, Seattle Division. In addition, Dr. Clausell serves as Lead Trainer and Consultant in VA Central Office of Family Services for the dissemination program of Integrative Behavioral Couple Therapy lead by Developer & Distinguished Research Professor Dr. Andrew Christensen, at University of California, Los Angeles. Currently, Dr. Clausell serves as clinical trainer and supervisor for Seattle VA’s Clinical training programs, including Predoctoral, Postdoctoral, and the University of Washington Department of Psychiatry and Behavioral Sciences Resident Program where he currently serves at Rotation Supervisor for the VA Outpatient Couple and Family Therapy Rotation.
Dr. Adam Kuczynski is a clinical psychologist and Acting Assistant Professor at the University of Washington School of Medicine, Department of Psychiatry and Behavioral Sciences. He received his PhD from the University of Washington in 2023 after completing his pre-doctoral internship at the same institution, training in serious mental illness and inpatient care at Harborview Medical Center and psycho-oncology Fred Hutch Cancer Center. Dr. Kuczynski currently works at the UW’s long-term civil commitment program and studies strategies to improve inpatient care for individuals with serious mental illness
Hello! I’m the medical director for the Long Term Civil Commitment Units at the Center for Behavioral Health and Learning. This is a new program as of July 2024 and I am excited to help get it off the ground. I completed my medical school training at the University of Cincinnati, then residency at Oregon Health & Science University, then addiction psychiatry fellowship at UW, then worked at the Puget Sound VA for five years and Providence Swedish for six years prior to starting at UW. I’m thrilled to be part of the team here and looking forward to this next chapter in my career.
I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.
I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.
My clinical and research interests center around behavioral and psychological symptoms that present in neurodegenerative diseases, especially dementias. Though dementia is well-known to affect one’s memory and cognition, over 90% of people with dementia develop new neuropsychiatric symptoms – including apathy, dysphoria. anxiety, aggression, agitation, disinhibition, hallucinations, and delusions. Despite the ubiquity of these symptoms, very little is known about how they develop in dementia. My research interests are in understanding more about the molecular and cellular mechanisms of neuropsychiatric symptoms in dementia beyond the well-studied changes associated with cognitive deficits.
Along with my research mentor Martin Darvas PhD (Department of Laboratory Medicine and Pathology), we employ numerous approaches to better understand these neuropsychiatric symptoms, including techniques involving transcriptomic analyses of human and mouse post-mortem tissue, development and implementation of biomarkers derived from human and animal model fluids (plasma, serum, cerebrospinal fluid), virally-mediated gene manipulations, animal modeling of cognitive and neuropsychiatric phenotypes, and basic cellular and molecular biology techniques.
I am a trained Behavioral Psychologist with a PhD in Health & Human Performance. The main goal of my work is to reduce substance-related harms and improve quality of life for people experiencing problems related to their substance use. I work closely with community members and people who use drugs to inform my line of research and address key needs identified. Most of my research is conducted at the Harm Reduction Research and Treatment (HaRRT) Center within the UW School of Medicine. My aim is to adapt, refine, and disseminate harm reduction programs through digital health interventions to empower individuals and ameliorate substance-related harms.
I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. I received my MD, MPH from the University of Nebraska Medical Center and completed my adult residency at the University of Washington where I was chief resident. I then went on to complete a fellowship in Consultation-Liaison Psychiatry at the University of Washington. I am currently on faculty at Harborview Medical Center on the inpatient psychiatry unit and inpatient psychiatry consult service. I have a longstanding interest in the intersection between medicine and psychiatry and in working with people who suffer from serious mental illness and treatment-resistant conditions. I have clinical interests in ECT, psychopharmacology, co-morbid medical conditions, and adjunctive psychotherapies. I value caring for the whole person through thorough and accurate diagnosis, treating co-morbid medical conditions, and minimizing medications when possible. I have teaching interests in reducing stigma surrounding serious mental illness and educating residents and medical students about psychiatric care.
Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
